Kraig Biocraft Laboratories (KBLB) Capital Expenditures (2010 - 2025)

Kraig Biocraft Laboratories (KBLB) reported Capital Expenditures of $1612.0 for Q4 2025, down 90.65% sequentially from $17233.0 in Q4 2021.

Kraig Biocraft Laboratories (KBLB) Capital Expenditures (2010 - 2025) Analysis & Trends

Kraig Biocraft Laboratories (KBLB) has 9 years of Capital Expenditures data on file, last reported at $1612.0 in Q4 2025.

For the quarter ending Q4 2025, Capital Expenditures changed N/A year-over-year to $1612.0; the trailing twelve-month figure through Dec 2025 stood at $18845.0 (changed N/A YoY), and the FY2025 full-year result was $5395.0, up 27.24% from the prior year.
Capital Expenditures slipped to $1612.0 in Q4 2025, from $17233.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $74801.0 in Q3 2021 to a low of $1612.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Linde	237.95 Bn	233.99 Bn	4.26 Bn	1.34 Bn
2	Sherwin Williams	78.17 Bn	77.95 Bn	2.78 Bn	138.30 Mn
3	Ecolab	76.02 Bn	75.37 Bn	1.85 Bn	332.10 Mn
4	Air Products & Chemicals	66.38 Bn	65.43 Bn	987.40 Mn	-
5	Ppg Industries	26.02 Bn	24.40 Bn	1.66 Bn	52.00 Mn
6	LyondellBasell Industries	22.51 Bn	19.87 Bn	701.00 Mn	269.00 Mn
7	Chemical & Mining Co Of Chile	19.70 Bn	15.83 Bn	778.60 Mn	-
8	International Flavors & Fragrances	19.51 Bn	18.95 Bn	1.02 Bn	97.00 Mn
9	DuPont de Nemours	18.80 Bn	18.71 Bn	602.00 Mn	102.00 Mn
10	Kraig Biocraft Laboratories	94.82 Mn	94.82 Mn	-	1,612.00

Download Data